The market often recognises a problem long before it understands the scale of the problem

A medicine becomes slightly harder to source.

Availability starts changing between suppliers.

Lead times move.

An occasional shortage notification appears.

At first, it looks like normal market noise.

Most of the time, that’s exactly what it is.

But sometimes those small changes are the first signs of something much larger.

The challenge for procurement teams is not seeing that a product has become unavailable. By that stage, the market is already reacting.

The challenge is understanding which early signals matter while there is still time to respond.

Looking back at the signals

We recently reviewed a watchlist of medicines that subsequently progressed to supply alerts, widespread out-of-stock events, price concessions or other forms of market disruption.

The products themselves were diverse. They spanned multiple therapeutic areas and included medicines used every day across primary and secondary care.

What stood out was not the products.

It was the timing.

In many cases, signs of increasing supply risk were visible long before the scale of the disruption became clear.

The market had started to recognise that something was changing.

What it could not yet see was where that change would lead.

Not every signal becomes a shortage

This is an important distinction.

Supply chains generate noise every day.

Availability changes.

Manufacturers experience temporary issues.

Demand fluctuates.

Most of these events resolve without significant consequences.

The objective is not to assume that every signal will become a shortage.

The objective is to identify when a pattern is beginning to emerge.

When multiple indicators start moving in the same direction, the conversation changes from routine market activity to potential supply risk.

Why timing matters

For procurement teams, visibility creates options.

Additional weeks or months of notice can provide opportunities to review sourcing strategies, assess alternatives and engage stakeholders before supply becomes critically constrained.

Once disruption becomes obvious, those options often become more limited.

Every organisation sees the same shortage eventually.

The difference lies in how early they see the conditions that precede it.

Seeing beyond the immediate issue

Medicine shortages are rarely defined by a single event.

They develop through a series of small changes that gradually alter market behaviour.

The difficulty is that these changes are often viewed in isolation.

A shortage notification here.

A supply issue there.

A change in availability somewhere else.

Individually, they may appear insignificant.

Viewed together, they can tell a very different story.

The value of earlier visibility

The organisations best positioned to manage supply risk are not necessarily those that react fastest.

They are the organisations that have more time to make decisions.

MedSupply Intelligence is designed to provide that earlier visibility.

Not to claim certainty about the future.

Not to generate unnecessary alerts.

But to help procurement teams identify meaningful changes before the scale of the problem becomes apparent to the wider market.

Because by the time everyone agrees there is a problem, the most valuable decisions have often already been made.